These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 16360064

  • 1. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial.
    Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA, Boehmer J, Singh S, Whellan DJ, Carson P, Boscoe A, Baker TM, Gunderman MR.
    J Am Coll Cardiol; 2005 Dec 20; 46(12):2311-21. PubMed ID: 16360064
    [Abstract] [Full Text] [Related]

  • 2. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG.
    Eur Heart J; 2007 Jan 20; 28(1):42-51. PubMed ID: 17110403
    [Abstract] [Full Text] [Related]

  • 3. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial.
    Carson P, Anand I, O'Connor C, Jaski B, Steinberg J, Lwin A, Lindenfeld J, Ghali J, Barnet JH, Feldman AM, Bristow MR.
    J Am Coll Cardiol; 2005 Dec 20; 46(12):2329-34. PubMed ID: 16360067
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial.
    Calvert MJ, Freemantle N, Yao G, Cleland JG, Billingham L, Daubert JC, Bryan S, CARE-HF investigators.
    Eur Heart J; 2005 Dec 20; 26(24):2681-8. PubMed ID: 16284203
    [Abstract] [Full Text] [Related]

  • 5. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.
    Anand IS, Carson P, Galle E, Song R, Boehmer J, Ghali JK, Jaski B, Lindenfeld J, O'Connor C, Steinberg JS, Leigh J, Yong P, Kosorok MR, Feldman AM, DeMets D, Bristow MR.
    Circulation; 2009 Feb 24; 119(7):969-77. PubMed ID: 19204305
    [Abstract] [Full Text] [Related]

  • 6. [Economic impact of cardiac resynchronization therapy in patients with heart failure. Available evidence and evaluation of the CRT-Eucomed model for analysis of cost-effectiveness].
    Fattore G, Landolina M, Bontempi L, Cacciatore G, Curnis A, Gulizia M, Padeletti L, Mazzei L, Tavazzi L, Gruppo di Studio congiunto Federazione Italiana di Cardiologia-Assobiomedica di Cardiologia-Assobiomedica "Valutazione del Medello CRT-Eucomed".
    Ital Heart J Suppl; 2005 Dec 24; 6(12):796-803. PubMed ID: 16444923
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD, Hlatky MA, Owens DK.
    N Engl J Med; 2005 Oct 06; 353(14):1471-80. PubMed ID: 16207849
    [Abstract] [Full Text] [Related]

  • 8. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR.
    J Card Fail; 2008 Feb 06; 14(1):9-18. PubMed ID: 18226768
    [Abstract] [Full Text] [Related]

  • 9. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.
    Health Technol Assess; 2007 Nov 06; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [Abstract] [Full Text] [Related]

  • 10. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
    Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F.
    Circulation; 2006 Dec 19; 114(25):2766-72. PubMed ID: 17159063
    [Abstract] [Full Text] [Related]

  • 11. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M.
    Circulation; 2007 Jan 16; 115(2):204-12. PubMed ID: 17190867
    [Abstract] [Full Text] [Related]

  • 12. Why should we care about CARE-HF?
    Ellenbogen KA, Wood MA, Klein HU.
    J Am Coll Cardiol; 2005 Dec 20; 46(12):2199-203. PubMed ID: 16360046
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH, SCD-HeFT Investigators.
    Circulation; 2006 Jul 11; 114(2):135-42. PubMed ID: 16818817
    [Abstract] [Full Text] [Related]

  • 14. Cost effectiveness of cardiac resynchronization therapy in Greece: an analysis based on the CArdiac REsychronization in Heart Failure trial.
    Maniadakis N, Ekman M, Calvert MJ, Freemantle N, Karamalis M, Vardas P.
    Europace; 2011 Nov 11; 13(11):1597-603. PubMed ID: 21821852
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C, Mealing S, Hawkins N, Eaton J, Brown B, Daubert JC, REVERSE study group.
    Eur Heart J; 2011 Jul 11; 32(13):1631-9. PubMed ID: 21112898
    [Abstract] [Full Text] [Related]

  • 16. Influence of left ventricular lead location on outcomes in the COMPANION study.
    Saxon LA, Olshansky B, Volosin K, Steinberg JS, Lee BK, Tomassoni G, Guarnieri T, Rao A, Yong P, Galle E, Leigh J, Ecklund F, Bristow MR.
    J Cardiovasc Electrophysiol; 2009 Jul 11; 20(7):764-8. PubMed ID: 19298563
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunction.
    Rinfret S, Cohen DJ, Lamas GA, Fleischmann KE, Weinstein MC, Orav J, Schron E, Lee KL, Goldman L.
    Circulation; 2005 Jan 18; 111(2):165-72. PubMed ID: 15630030
    [Abstract] [Full Text] [Related]

  • 18. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK, Boehmer J, Feldman AM, Saxon LA, Demarco T, Carson P, Yong P, Galle EG, Leigh J, Ecklund FL, Bristow MR.
    J Card Fail; 2007 Nov 18; 13(9):769-73. PubMed ID: 17996827
    [Abstract] [Full Text] [Related]

  • 19. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N, Furlong W, Perkins A, Feeny D, Torrance GW.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct 18; 15(5):608-15. PubMed ID: 18800005
    [Abstract] [Full Text] [Related]

  • 20. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A, Stone GW, Mahoney E, Lavelle TA, Shi C, Berezin RH, Lahue BJ, Clark MA, Lacey MJ, Russell ME, Ellis SG, Hermiller JB, Cox DA, Cohen DJ, TAXUS-IV Investigators.
    J Am Coll Cardiol; 2006 Jul 18; 48(2):253-61. PubMed ID: 16843171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.